Well — almost four full years after the cases were first filed by the Gennessee County (NJ) Retirement System (pension fund investors) and individuals like Richard Manson, the claims that officers of legacy Schering-Plough wrongfully delayed disclosure of the ill-starred ENHANCE clinical trials, to prop up Schering-Plough’s flagging stock are now set for trial, in the federal District Courthouse in Newark, New Jersey, thus:
. . . .This Court having reviewed the docket in this case and finding no Order scheduling the trial of this matter after the September 26, 2011 status conference; and For good cause shown;
It is on this 6th day of August 2012 ORDERED that the Trial in this matter is hereby set for Tuesday November 13, 2012 at 9:30 a.m., and
It is further ORDERED that counsel are to proceed with the Final Pretrial Conference before Magistrate Judge Joseph A. Dickson.
These are the cases featuring testimony from up to six confidential internal Schering-Plough witnesses — as to what Carrie Cox and Fred Hassan knew — and when they knew it, about the ENHANCE null-result.
Do stay tuned, as November approaches — I predict an eve of trial settlement — in the mid-to-high hundreds of millions of dollars. [However, as to the behemoth that is the New Merck (~$50 billion in annual revenue), even that amount would scarcely be material.]